Lopinavir/ritonavir dosing during pregnancy in Brazil and maternal/infant laboratory abnormalities

OBJECTIVES: To describe laboratory abnormalities among HIV-infected women and their infants with standard and increased lopinavir/ritonavir (LPV/r) dosing during the third trimester of pregnancy. METHODS: We evaluated data on pregnant women from NISDI cohorts (2002-2009) enrolled in Brazil, who received at least 28 days of LPV/r during the third pregnancy trimester and gave birth to singleton infants. RESULTS: 164 women received LPV/r standard dosing [(798/198 or 800/200 mg/day) (Group 1)] and 70 increased dosing [(> 800/200 mg/day) (Group 2)]. Group 1 was more likely to have advanced clinical disease and to use ARVs for treatment, and less likely to have CD4 counts > 500 cells/mm³. Mean plasma viral load was higher in Group 2. There were statistically significant, but not clinically meaningful, differences between groups in mean AST, ALT, cholesterol, and triglycerides. The proportion of women with Grade 3 or 4 adverse events was very low, with no statistically significant differences between groups in severe adverse events related to ALT, AST, total bilirubin, cholesterol, or triglycerides. There were statistically significant, but not clinically meaningful, differences between infant groups in ALT and creatinine. The proportion of infants with Grade 3 or 4 adverse events was very low, and there were no statistically significant differences in severe adverse events related to ALT, AST, BUN, or creatinine. CONCLUSION: The proportions of women and infants with severe laboratory adverse events were very low. Increased LPV/r dosing during the third trimester of pregnancy appears to be safe for HIV-infected women and their infants.Eunice Kennedy Shriver - National Institute of Child Health and Human Development (NIH

COLONIZAÇÃO MATERNA POR ESTREPTOCOCOS DO GRUPO B: PREVALÊNCIA ESUSCETIBILIDADE AOS ANTIMICROBIANOS / GROUP B STREPTOCOCCUS COLONIZATION IN PREGNANT WOMEN: PREVALENCE AND ANTIMICROBIAL SUSCEPTIBILITY

Introdução: Estreptococos do Grupo B (EGB) é um importante agente etiológico de infecção neonatal e a colonização das mucosas vaginal/anal materna é fator de risco para transmissão vertical dessa bactéria. Objetivo: Avaliar a prevalência de colonização de mucosas vaginal e anal pelo EGB em gestantes a partir da 35 semana, características sócio-demográficas e clínicas desta o população e o espectro de susceptibilidade aos antimicrobianos. Métodos: Coorte prospectiva incluindo 108 gestantes admitidas no serviço de Ginecologia e Obstetrícia do Hospital das Clínicas de Uberlândia, de fevereiro de 2011 a julho de 2011. A coleta de material clínico foi realizada por meio de dois swabs. As culturas positivas foram identificadas pelas características: morfo-tinturiais, testes de CAMP e de aglutinação em látex. Os dados foram por meio de consultas aos  prontuários e entrevistas. Para o cálculo do valor p utilizou-se o teste exato de Fisher (SAS versão 9.2). Resultados: A taxa de colonização por EGB foi alta, (17,5%). O perfil sócio-demográfico evidenciou mulheres com idade média de 24 anos, casadas/união estável (84,2%), multigestas(61,3%), histórico de aborto em 15,7%. As frequências de amostras resistentes a clindamicina e eritromicina foram de 10,6% e 12,6%, respectivamente. Conclusão: Os resultados evidenciaram uma alta taxa de colonização materna pelo EGB, sobretudo na mucosa vaginal, em  mulheres jovens e multigestas. As amostras de EGB apresentaram frequências baixas de resistência a clindamicina e eritromicina.Palavras-chave: Streptococcus agalactiae. Colonização. Gestantes.AbstractIntroduction: Group B streptococcus is an important etiological agent of newborn infections and the maternal mucosa (vaginal/ anal) colonization is a risk factor to vertical transmission of this bacteria. Objective: To evaluate the occurrence of vaginal and anal colonization by Group B streptococcus in pregnant women from 35 week, clinical and sociodemographic data and to evaluate the susceptibility of the isolates to antimicrobial agents. Methods: Prospective cohort study including 108  pregnant women attended at the Gynecology and Obstetrics settings of the Hospital das Clínicas de Uberlândia between February 2011 to July 2011. The clinical specimens were obtained by two swabs. The positive cultures were indentified through the following characteristics: colony morphology, CAMP and serological test. Maternal risk factors associated to colonization was obtained to medical records and interview. The p-value was calculated through SAS software, 9.2. version. Results: The frequency of colonizationwas high (17.5%). The pregnant women sociodemographical profile evidenced the following characteristics: mean age of 24 years, married/stable union (82.4%), multiparity (61.3%), previous abortion (15.7%). Resistance to clindamycin and erythromycin was detected in 10.6 and 12.6% of the isolates, respectively. Conclusion: The results evidenced a high rate of vaginal GBS colonization, in young and multiparous women. The GBS samples presented low frequencies of clindamycin anderythromycin resistance.Keywords: Streptococcus agalactiae. Colonization. Pregnant women

Vitamin A, vitamin E, iron and zinc status in a cohort of HIV-infected mothers and their uninfected infants

Introduction We hypothesized that nutritional deficiency would be common in a cohort of postpartum, human immunodeficiency virus (HIV)-infected women and their infants. Methods Weight and height, as well as blood concentrations of retinol, α-tocopherol, ferritin, hemoglobin, and zinc, were measured in mothers after delivery and in their infants at birth and at 6-12 weeks and six months of age. Retinol and α-tocopherol levels were quantified by high performance liquid chromatography, and zinc levels were measured by atomic absorption spectrophotometry. The maternal body mass index during pregnancy was adjusted for gestational age (adjBMI). Results Among the 97 women 19.6% were underweight. Laboratory abnormalities were most frequently observed for the hemoglobin (46.4%), zinc (41.1%), retinol (12.5%) and ferritin (6.5%) levels. Five percent of the women had mean corpuscular hemoglobin concentrations \u3c 31g/dL. The most common deficiency in the infants was α-tocopherol (81%) at birth; however, only 18.5% of infants had deficient levels at six months of age. Large percentages of infants had zinc (36.8%) and retinol (29.5%) deficiencies at birth; however, these percentages decreased to 17.5% and 18.5%, respectively, by six months of age. No associations between infant micronutrient deficiencies and either the maternal adjBMI category or maternal micronutrient deficiencies were found. Conclusions Micronutrient deficiencies were common in HIV-infected women and their infants. Micronutrient deficiencies were less prevalent in the infants at six months of age. Neither underweight women nor their infants at birth were at increased risk for micronutrient deficiencies

Seroprevalence of antibodies for toxoplasmosis, rubella, cytomegalovirus, syphilis and HIV among pregnant women in Sergipe

Averiguou-se a soroprevalência para HIV, sífilis, toxoplasmose, citomegalovirose e rubéola em gestantes de Sergipe, nordeste do Brasil, verificando-se a associação com idade e procedência. Selecionaram-se 9.550 gestantes (2.112 da capital e 7.438 do interior) testadas consecutivamente durante o primeiro atendimento pré-natal em 2007. Foram encontradas as seguintes frequências de soropositividade: sífilis (0,9%; IC95% 0,7%-1,6%), HIV (0,14%; IC95% 0,08%-0,2%), toxoplasmose (IgG 69,3%; IC95% 68,3%-70,2%; IgM 0,4%, IC95% 0,3%-0,6%), citomegalovirose (IgG 76,6%, IC95% 75,7%-77,5%; IgM 0,2%, IC95% 0,09%-0,3%) e rubéola (IgG 71,6%, IC95% 70,7%-72,6%; IgM 0,1%, IC95% 0,04%-0,2%). A soropositividade para toxoplasmose incrementou com a idade. A prevalência de anticorpos IgG para toxoplasmose, CMV e rubéola foi maior na capital, Aracaju, que nos demais municípios do Estado de Sergipe. Foi encontrada associação entre a idade e soropositividade para a toxoplasmose. Os achados revelam grande proporção de gestantes susceptíveis a toxoplasmose, rubéola e citomegalovirose, principalmente no interior do estado, com risco para seus filhos. ________________________________________________________________________________________ ABSTRACT: The seroprevalence of antibodies for HIV, syphilis, toxoplasmosis, cytomegalovirosis and rubella and its association with age and origin was investigated among pregnant women in Sergipe, northeastern Brazil. A total of 9,550 pregnant women (2,112 from the state capital and 7,438 from other municipalities) were enrolled in the study and consecutively tested during their first antenatal care visit in 2007. The following serum prevalences were found: syphilis (0.9%; 95% CI 0.7%-1.6%), HIV (0.14%; 95% CI 0.08%-0.2%), toxoplasmosis (IgG 69.3%; 95% CI 68.3%-70.2%; IgM 0.4%, 95% CI 0.3%-0.6%), cytomegalovirosis (IgG 76.6%, 95% CI 75.7%-77.5%; IgM 0.2%, 95% CI 0.09%-0.3%) and rubella (IgG 71.6%, 95% CI 70.7%-72.6%; IgM 0.1%, 95% CI 0.04%-0.2%). Toxoplasmosis seropositivity increased with age. The prevalences of IgG antibodies for toxoplasmosis, cytomegalovirus and rubella were higher in Aracaju (state capital) than in other municipalities in the State of Sergipe. The results showed that a large proportion of the pregnant women, particularly in municipalities other than the state capital, were susceptible to toxoplasmosis, rubella and cytomegalovirus, with a risk for their infants

Vitamin A, vitamin E, iron and zinc status in a cohort of HIV-infected mothers and their uninfected infants

Introduction We hypothesized that nutritional deficiency would be common in a cohort of postpartum, human immunodeficiency virus (HIV)-infected women and their infants. Methods Weight and height, as well as blood concentrations of retinol, α-tocopherol, ferritin, hemoglobin, and zinc, were measured in mothers after delivery and in their infants at birth and at 6-12 weeks and six months of age. Retinol and α-tocopherol levels were quantified by high performance liquid chromatography, and zinc levels were measured by atomic absorption spectrophotometry. The maternal body mass index during pregnancy was adjusted for gestational age (adjBMI). Results Among the 97 women 19.6% were underweight. Laboratory abnormalities were most frequently observed for the hemoglobin (46.4%), zinc (41.1%), retinol (12.5%) and ferritin (6.5%) levels. Five percent of the women had mean corpuscular hemoglobin concentrations < 31g/dL. The most common deficiency in the infants was α-tocopherol (81%) at birth; however, only 18.5% of infants had deficient levels at six months of age. Large percentages of infants had zinc (36.8%) and retinol (29.5%) deficiencies at birth; however, these percentages decreased to 17.5% and 18.5%, respectively, by six months of age. No associations between infant micronutrient deficiencies and either the maternal adjBMI category or maternal micronutrient deficiencies were found. Conclusions Micronutrient deficiencies were common in HIV-infected women and their infants. Micronutrient deficiencies were less prevalent in the infants at six months of age. Neither underweight women nor their infants at birth were at increased risk for micronutrient deficiencies

Frequency of pregnant women with HBsAg in a Brazilian community Freqüência de gestantes portadoras do HBsAg em uma comunidade brasileira

The work reported here points up the real benefits provided by neonatal immunoprophylaxis of newborns delivered by mothers who are seropositive for the hepatitis B virus surface antigen HBsAg and underscores the need to properly identify such mothers in Brazil so that immunoprophylaxis can be undertaken. To help determine levels of hepatitis B virus (HBV) infection and seropositivity for various HBV markers among pregnant women in Southeast Brazil, investigators studied 7992 pregnant women delivering at the Clinical Hospital of the University of São Paulo's Ribeirão Preto School of Medicine in Ribeirão Preto, Brazil. Seroreactivity for HBsAg was determined first by serologic screening with an enzyme-linked immunosorbent assay (ELISA) procedure in which the sera were incubated for 2 hours and then by confirmation with another ELISA in which the sera were incubated for 18 hours. Subsequently, tests for anti-HBsAg, HBeAg, anti-HBeAg, and anti-HBcAg markers were conducted using confirmed positive samples. Initial screening found 84 of the 7992 samples (1.05%, 95% CI: 0.84-1.30) to be positive for HBsAg; however, this HBsAg positivity was confirmed in only 76 (0.95%, 95% CI: 0.75-1.19). The positivity rate was significantly higher among subjects whose pregnancies terminated in miscarriage (1.84%) than among those with live births (0.83%) (chi2, Yates correction = 7.6; P = 0.005). Anamnesis was able to identify HBV risk factors in only 27.6% of the confirmed HBsAg-positive subjects or close household contacts. However, 21.3% (95% CI: 1.04-30.56) of the confirmed HBsAg-positive subjects were found positive for HBeAg, indicating a high risk of vertical transmission of the virus. These results demonstrate a need to conduct specific serologic research at term, in order to provide effective neonatal immunoprophylactic benefits.<br>Visando aferir a tasa de reatividade sérica do HBsAg e de outros marcadores da infecção pelo VHB em parturientes, além de avaliar quais os fatores de risco, estudaram-se 7992 mulheres que tiveram suas gestações resolvidas no Hospital das Clínicas da Universidade de São Paulo. A reatividade sérica do HBsAg foi aferida por o teste ELISA em duas etapas: a primeira com período de incubação de 2 h (triagem) e a segunda de 18 horas (confirmatória) realizada nas amostras positivas ao triagem. Os marcadores anti-HBsAg, HBeAg, anti-HBeAg, e anti-HBcAg foram testados nas amostras confirmadamente positivas. No triagem, foram positivas para o HBsAg 1,05% (IC95%; 0,84-1,30) das amostras. Apenas 0,95% (IC95%; 0,75-1,19) foram confirmadamente positivas, sendo significativamente superior nas pacientes cujas gestações terminaram em aborto (1,84%) do que as 0,84% que terminaram em parto (chi2 correção de Yates = 7,76; P < 0,005). A anamnese possibilitou identificar fatores de risco para a infecção pelo VHB em apenas 27,6% das pacientes avaliadas. Dessas amostras, 21,3% (IC95%; 1,04-30,56) apresentavam HBeAg positivo, de elevado risco para transmissão vertical desse vírus. Esses resultados reforçam a necessidade de pesquisa sorológica específica no final da gestação, possibilitando o máximo benefício da imunoprofilaxia neonatal